Related Experiment Video
Updated: Jun 26, 2026

Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
Published on: May 12, 2019
Biomarkers for nononcologic gastrointestinal diseases
1Department of Medicine, Division of Allergy and Immunology, National Jewish Health, 1400 Jackson Street, J329, Denver, CO 80206, USA. katialr@njc.org
Biomarker research in gastrointestinal diseases often focuses on cancer. This review explores biomarkers for non-cancerous gastrointestinal conditions, particularly allergic disorders, highlighting current knowledge gaps.
Area of Science:
- Gastroenterology
- Immunology
- Biomarker Discovery
Background:
- Biomarkers indicate biological processes and therapeutic responses.
- Gastrointestinal (GI) biomarker research predominantly targets cancer.
- Limited understanding exists regarding biomarkers for non-oncologic GI disorders.
Purpose of the Study:
- To review existing biomarker data for non-oncologic GI conditions.
- To focus specifically on biomarkers relevant to GI allergic disorders.
- To identify research gaps in this field.
Main Methods:
- Literature review of scientific articles.
- Synthesis of data on biomarkers in non-oncologic GI diseases.
- Emphasis on allergic GI conditions.
Main Results:
- Biomarker research in GI diseases is heavily skewed towards oncology.
- Data on biomarkers for non-oncologic GI conditions, especially allergies, is scarce.
- Significant knowledge gaps exist in understanding GI biomarkers beyond cancer.
Conclusions:
- There is a critical need for expanded biomarker research in non-oncologic GI diseases.
- Focusing on allergic disorders can reveal novel diagnostic and therapeutic indicators.
- Future research should aim to fill the existing knowledge void in GI biomarker discovery.
Related Concept Videos
Serum Laboratory Studies, Stool Test, Breath Test
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and solid...
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems related to...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
